Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the United States against Amgen ...

The German parliament plans to meet on May 6 to elect Friedrich Merz as the country’s next leader, if all the parties in his ...

Friedrich Merz, leader of the conservative German party CDU is set to be elected chancellor on May 6, party sources said on ...

Dr. Merz joined ProBioGen in 2024 from Bayer Pharmaceuticals, where he served as Senior Vice President and Head of Product Supply Medical Devices. With over 30 years of international experience in ...

Simply sign up to the German politics myFT Digest -- delivered directly to your inbox. As Friedrich Merz moves closer to power, the women in his Christian Democratic Union fear they will be kept ...

CDU leader Friedrich Merz and other CDU and SPD leaders take part in a press conference following the exploratory coalition talks, Berlin, Germany, March 8, 2025 (DPA photo by Michael Kappeler AP ...

US President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs. Trump was speaking as he announced 25% tariffs on cars and car parts imported into the US.

Trump has announced 25% tariffs on cars and car parts imported into the US US President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs. Trump was ...

DUBLIN, March 26, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 24 th Annual Needham Healthcare Conference. Company ...

Looking ahead, this article highlights the key trends expected to shape the regulatory landscape of pharmaceutical manufacturing in 2025. Regulatory agencies—including the U.S. Food and Drug ...

Alternative for Germany has hit an all-time high in polling amid a backlash to its conservative rivals’ promise to hugely increase debt to fund military spending. The poll by INSA showed the AfD ...

There remains much uncertainty about these measures, however. As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news.